Boston Research & Management’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.82M Buy
15,768
+438
+3% +$207K 1.86% 15
2025
Q4
$6.54M Sell
15,330
-612
-4% -$262K 1.51% 24
2025
Q3
$7.57M Buy
15,942
+86
+0.5% +$40.7K 1.67% 20
2025
Q2
$7.44M Buy
15,856
+64
+0.4% +$29.2K 1.78% 18
2025
Q1
$7.35M Sell
15,792
-223
-1% -$100K 1.83% 19
2024
Q4
$6.71M Sell
16,015
-27
-0.2% -$12.3K 1.65% 21
2024
Q3
$7.65M Sell
16,042
-415
-3% -$189K 1.8% 18
2024
Q2
$7.22M Sell
16,457
-218
-1% -$95.9K 1.83% 15
2024
Q1
$7.74M Sell
16,675
-2
-0% -$866 1.91% 14
2023
Q4
$6.85M Buy
16,677
+24
+0.1% +$9.46K 1.82% 15
2023
Q3
$6.2M Sell
16,653
-179
-1% -$68.1K 1.83% 15
2023
Q2
$6.41M Sell
16,832
-237
-1% -$86.6K 1.82% 18
2023
Q1
$6.07M Sell
17,069
-177
-1% -$59.3K 1.81% 17
2022
Q4
$5.63M Sell
17,246
-352
-2% -$110K 1.74% 20
2022
Q3
$4.74M Buy
17,598
+595
+3% +$171K 1.62% 21
2022
Q2
$4.89M Sell
17,003
-31
-0.2% -$9.68K 1.58% 25
2022
Q1
$5.44M Sell
17,034
-466
-3% -$144K 1.58% 20
2021
Q4
$6.06M Sell
17,500
-214
-1% -$69.3K 1.66% 23
2021
Q3
$5.2M Sell
17,714
-150
-0.8% -$45.6K 1.55% 27
2021
Q2
$5.16M Buy
17,864
+14
+0.1% +$4.08K 1.57% 27
2021
Q1
$5M Buy
17,850
+365
+2% +$94.7K 1.61% 27
2020
Q4
$4.61M Buy
17,485
+179
+1% +$43.9K 1.6% 26
2020
Q3
$4.12M Sell
17,306
-775
-4% -$188K 1.61% 29
2020
Q2
$3.83M Buy
18,081
+841
+5% +$162K 1.59% 29
2020
Q1
$2.98M Sell
17,240
-400
-2% -$78.9K 1.5% 32
2019
Q4
$3.75M Sell
17,640
-335
-2% -$67.5K 1.41% 42
2019
Q3
$3.48M Buy
17,975
+835
+5% +$162K 1.38% 40
2019
Q2
$3.44M Buy
17,140
+100
+0.6% +$18.7K 1.39% 38
2019
Q1
$3M Buy
17,040
+2,110
+14% +$351K 1.25% 42
2018
Q4
$2.33M Buy
+14,930
New +$2.36M 1.11% 44

Other funds holding LIN

Boston Research & Management's LIN Position: Q1 2026 in Review

Boston Research & Management increased its Linde (LIN) stake by 2.9% in Q1 2026, buying an estimated $207K and bringing the position to 15,768 shares worth $7.82M. The position accounts for 1.86% of the portfolio, ranked #15.

Boston Research & Management first reported a position in LIN in Q4 2018 and has held it in 30 quarters since. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Boston Research & Management held 15,768 shares of Linde worth $7.82M as of Q1 2026.
  • Boston Research & Management bought 438 Linde shares in Q1 2026, an estimated $207K.
  • Linde made up 1.86% of Boston Research & Management's portfolio in Q1 2026, its #15 holding.
  • Boston Research & Management first reported a position in Linde in Q4 2018 and has held it in 30 quarters since.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.